InTandem Capital Partners has announced it has completed an investment in Clinilabs.

Clinilabs, founded in 2000 and based in Eatontown, New Jersey, is a contract research organization focused on central nervous system drug, device and technology development.

InTandem, founded in 2011 and based in New York, focuses on acquiring middle market healthcare services companies. The firm prefers to make more substantial investments from a dollars perspective in the provider services and non-reimbursement industries.

Terms of the investment were not disclosed.